First-in-class antidepressant prevents relapse

摘要

A new type of antidepressant could help to prevent patients from relapsing.First-in-class agomelatine acts as an agonist at melatonergic MT_1/MT_2 receptors and as an antagonist at 5-HT_(2C) receptors.New data presented at the European College of Neuropsychopharmacology annual congress,held in Vienna last month,suggest a 54 per cent relative reduction in risk of relapse of depression for agomelatine-treated patients.